| scholarly article | Q13442814 |
| P50 | author | Graham Rook | Q43849836 |
| P2093 | author name string | D N McMurray | |
| S W Phalen | |||
| J L Stanford | |||
| H Abbey | |||
| A M Dannenberg | |||
| J E Estep | |||
| M L Pitt | |||
| P J Converse | |||
| T Shigenaga | |||
| T Koru-Sengul | |||
| P2860 | cites work | A comparative study of the virulence of mycobacterium tuberculosis measured in mice and guinea pigs | Q93802425 |
| The instructive role of innate immunity in the acquired immune response | Q34375203 | ||
| The Th1/Th2 paradigm | Q34429440 | ||
| Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli | Q35529843 | ||
| A histochemical study of phagocytic and enzymatic functions of rabbit mononuclear and polymorphonuclear exudate cells and alveolar macrophages. I. Survey and quantitation of enzymes, and states of cellular activation | Q36185532 | ||
| Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function | Q36350855 | ||
| Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis | Q37066653 | ||
| Cytokines and the Koch phenomenon | Q37282066 | ||
| Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis | Q37794086 | ||
| Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa. | Q39325665 | ||
| T cell helper types and endocrines in the regulation of tissue-damaging mechanisms in tuberculosis | Q40505145 | ||
| New concepts for the control of tuberculosis in the twenty first century | Q40848880 | ||
| Studies of vaccination of persons in close contact with leprosy patients in Argentina | Q40849234 | ||
| Immunosuppression in tuberculosis. | Q41043196 | ||
| Regulation of the human immune response in tuberculosis. | Q41043210 | ||
| Pathogenesis of experimental tuberculosis in animal models | Q41100744 | ||
| The expanding universe of T-cell subsets: Th1, Th2 and more. | Q41120396 | ||
| The pathogenesis of tuberculosis | Q41199562 | ||
| Immunotherapy with Mycobacterium vaccae and the treatment of tuberculosis. | Q41277227 | ||
| Innate immunity: impact on the adaptive immune response | Q41353080 | ||
| Review: the immune response in human tuberculosis--implications for tuberculosis control | Q41634725 | ||
| Regulation of the human immune response during tuberculosis. | Q41656277 | ||
| Liquefaction of caseous foci in tuberculosis | Q43446242 | ||
| Constitutional factors in resistance to infection; the effect of cortisone on the pathogenesis of tuberculosis | Q43651777 | ||
| Evaluation of the method of quantitative airborne infection and its use in the study of the pathogenesis of tuberculosis | Q44412234 | ||
| Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs | Q46734579 | ||
| Two potential improvements to BCG and their effect on skin test reactivity in the Lebanon. | Q50571447 | ||
| Recognition of a category of responders to group II, slow-grower associated antigens amongst Kuwaiti senior school children, using a statistical model. | Q52548575 | ||
| Host-parasite relationships in natively resistant and susceptible rabbits on quantitative inhalation of tubercle bacilli. Their significance for the nature of genetic resistance. | Q52626742 | ||
| Prevention of tuberculous cavity formation by desensitization with tuberculin-active peptide. | Q54063082 | ||
| Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. | Q54265963 | ||
| The response to the intracutaneous inoculation of BCG as an index of native resistance to tuberculosis. | Q54747814 | ||
| The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance | Q58826918 | ||
| TH1/TH2 switching and loss of CD4+ T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV | Q58826939 | ||
| The meaning and structure of species as applied to mycobacteria | Q68370935 | ||
| Macrophage accumulation, division, maturation, and digestive and microbicidal capacities in tuberculous lesions. 3. The turnover of macrophages and its relation to their activation and antimicrobial immunity in primary BCG lesions and those of reinf | Q70496972 | ||
| The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG | Q70890981 | ||
| Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed disease | Q73152176 | ||
| Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series | Q73322536 | ||
| On the nature of genetic resistance to tuberculosis in the light of the host-parasite relationships in natively resistant and susceptible rabbits | Q73785099 | ||
| Lurie's tubercle-count method to test TB vaccine efficacy in rabbits | Q88012637 | ||
| P433 | issue | 6 | |
| P921 | main subject | tuberculin | Q29505 |
| Mycobacterium tuberculosis | Q130971 | ||
| Mycobacterium vaccae | Q655983 | ||
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 871-881 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Pulmonary bovine-type tuberculosis in rabbits: bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy | |
| P478 | volume | 5 |
| Q37469326 | Clinical and diagnostic developments of a gamma interferon release assay for use in bovine tuberculosis control programs. |
| Q36046773 | Different Strains ofMycobacterium tuberculosisCause Various Spectrums of Disease in the Rabbit Model of Tuberculosis |
| Q28386031 | Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus) |
| Q54213684 | Diverse cavity types and evidence that mechanical action on the necrotic granuloma drives tuberculous cavitation. |
| Q36171653 | Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography |
| Q40568831 | Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing |
| Q34189865 | Perspectives on Clinical and Preclinical Testing of New Tuberculosis Vaccines |
| Q34708437 | Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice |
| Q36571064 | Susceptibility to tuberculosis: composition of tuberculous granulomas in Thorbecke and outbred New Zealand White rabbits |
| Q55250836 | The wide utility of rabbits as models of human diseases. |
| Q36363532 | Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system |
| Q36747136 | Use of gene dosage effects for a whole-genome screen to identify Mycobacterium marinum macrophage infection loci |
| Q34001917 | Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. |
Search more.